Viewing StudyNCT00116597



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00116597
Status: COMPLETED
Last Update Posted: 2009-12-02
First Post: 2005-06-29

Brief Title: Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma
Sponsor: University Hospital Basel Switzerland
Organization: University Hospital Basel Switzerland

Conditions & Keywords Data

Conditions:
Name
Melanoma
Keywords:
Name View
Phase III View
Active Specific Immunotherapy View
Intranodal View
Cancer View
Melanoma stages IIb to IV View
Gene Therapy View
Recombinant Vaccinia virus View
HLA-A2 View
Mart-1Melan-A Gp-100 tyrosinase View
Clinical Trial View